TH003-02

N/A

Report date: 2025/02/20 16:25:15

Base Information

Drug NameTH003-02
Drug Alias NameTH003-02TH-003-02
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionB-cell activating factor receptor inhibitors
TargetsB-cell activating factor receptor
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Bangentai Biomedical Tech Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Bangentai Biomedical Tech Group Co Ltd
Inactive CompaniesN/A
Active IndicationsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A